New York lawsuit puts 3M stock under closer scrutiny

3M (MMM) is back in focus after New York Attorney General Letitia James filed a lawsuit accusing the company and several peers of decades-long PFAS contamination tied to certain consumer products.

The case centers on allegations that 3M and others manufactured, marketed, and sold PFAS chemicals while knowing about their toxicity and persistence, with New York seeking cleanup funding, consumer warnings, changes to advertising, and financial penalties.

At a share price of $155.34, 3M’s recent legal headline arrives after mixed momentum. The stock has recorded a 3.34% 90-day share price return, but a year-to-date share price return that is down 4%. The 3-year total shareholder return of 98.21% contrasts with a far smaller 1-year total shareholder return of 0.59%, which may suggest that earlier enthusiasm has cooled.

If this legal setback has you reassessing individual risks, it can help to balance your watchlist with other industrial and infrastructure opportunities, including 34 power grid technology and infrastructure stocks

With 3M stock up over the past 90 days but still down year to date, the real tension is whether recent weakness already reflects legal and business risks, or whether patience could offer a more attractive entry as valuations reset.

Most Popular Narrative: 9.1% Undervalued

Compared with 3M's last close at $155.34, the most followed narrative sees fair value at $170.97, using a detailed forecast of earnings, margins, and cash flows discounted at 7.61%.

Significant operational efficiency gains, such as improved on-time delivery, increased equipment effectiveness, quality cost reductions, and supply chain/process consolidation, are driving structurally higher operating margins and earnings benefits expected to compound as further optimization and automation are rolled out company-wide.

Want to see how this efficiency story connects to 3M's projected revenue path, margin rebuild, and future earnings power? The underlying assumptions are sharper than the headline suggests.

Result: Fair Value of $170.97 (UNDERVALUED)

However, this 3M narrative still leans heavily on smooth execution, with unresolved PFAS litigation and slower than expected organic sales growth both capable of undermining the current thesis.

Next Steps

If this combination of legal pressure and efficiency-driven optimism around 3M seems closely balanced, consider promptly reviewing both sides of the story yourself using the 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond 3M?

If 3M has sharpened your focus on risk and reward, do not stop here. Broaden your watchlist with other clear, data driven ideas from the Simply Wall St screener.

• Target resilient cash generators by reviewing companies in the solid balance sheet and fundamentals stocks screener (47 results).
• Spot potential mispricings early by scanning the screener containing 19 high quality undiscovered gems before they appear on everyone else's radar.
• Prioritize sleep at night holdings by checking stocks in the 73 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.